Hemophilia, The Musical? It ’s Funded By Biotech BioMarin

Rare disease drug company BioMarin put on a show called ‘Hemophilia: The Musical’ performed by teenagers affected by blood disorders.

Source: Forbes.com Healthcare News - November 16, 2018 Category: Pharmaceuticals Authors: Michela Tindera, Forbes Staff Source Type: news